Narjust Florez/LinkedIn
May 30, 2025, 18:38
Narjust Florez: EQUAL Study on Early EGFR Lung Cancer Diagnosis will be Presented at ASCO25
Narjust Florez, Co-Director of the Young Lung Cancer Program at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“Our study in progress, EQUAL, which aims to evaluate a novel blood assay for early diagnosis of EGFR lung cancer, will be presented at ASCO25 during the Monday poster session. See you there!”
More posts featuring Narjust Florez.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 6, 2025, 20:03
Aug 6, 2025, 18:22
Aug 6, 2025, 18:03